{"podcast":{"title":"Mendelspod Podcast","slug":"mendelspod-podcast-742570","podcast_index_feed_id":742570,"rss_url":"https://api.substack.com/feed/podcast/1880068.rss","website_url":"https://www.mendelspod.com/podcast","image_url":"https://substackcdn.com/feed/podcast/1880068/5bb25823a5924e02541adbfe80ce5c07.jpg","author":"Theral Timpson","episode_count":556,"summary":"The 21st is the Century of Biology. A radical advancement in the knowledge of basic biology and human disease is transforming our world. We interview the heroes beneath the headlines.","last_synced_at":"2026-06-26T06:20:16.118421+00:00","page_url":"https://stenobird.com/podcast/mendelspod-podcast-742570"},"episodes":[{"title":"Can Liquid Biopsy Transform Chronic Disease? Hamed Amini and Soheil Damangir of Hepta","slug":"can-liquid-biopsy-transform-chronic-disease-hamed-amini-and-soheil-damangir-of-hepta","published_at":"2026-06-25T16:33:51+00:00","page_url":"https://stenobird.com/podcast/mendelspod-podcast-742570/can-liquid-biopsy-transform-chronic-disease-hamed-amini-and-soheil-damangir-of-hepta","url":"https://www.mendelspod.com/p/can-liquid-biopsy-transform-chronic","duration_seconds":299,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/mendelspod-podcast-742570/episodes/can-liquid-biopsy-transform-chronic-disease-hamed-amini-and-soheil-damangir-of-hepta/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/mendelspod-podcast-742570/can-liquid-biopsy-transform-chronic-disease-hamed-amini-and-soheil-damangir-of-hepta.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]},{"title":"The UAE’s Big Bet on Genomic Medicine with Mohamed Alameri and Albarah El-Khani","slug":"the-uae-s-big-bet-on-genomic-medicine-with-mohamed-alameri-and-albarah-el-khani","published_at":"2026-06-23T15:46:25+00:00","page_url":"https://stenobird.com/podcast/mendelspod-podcast-742570/the-uae-s-big-bet-on-genomic-medicine-with-mohamed-alameri-and-albarah-el-khani","url":"https://www.mendelspod.com/p/the-uaes-big-bet-on-genomic-medicine","duration_seconds":2786,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/mendelspod-podcast-742570/episodes/the-uae-s-big-bet-on-genomic-medicine-with-mohamed-alameri-and-albarah-el-khani/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/mendelspod-podcast-742570/the-uae-s-big-bet-on-genomic-medicine-with-mohamed-alameri-and-albarah-el-khani.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]},{"title":"Ryan Flynn of Harvard on Non-Coding RNA","slug":"ryan-flynn-of-harvard-on-non-coding-rna","published_at":"2026-06-18T15:25:36+00:00","page_url":"https://stenobird.com/podcast/mendelspod-podcast-742570/ryan-flynn-of-harvard-on-non-coding-rna","url":"https://www.mendelspod.com/p/ryan-flynn-of-harvard-on-non-coding","duration_seconds":2471,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/mendelspod-podcast-742570/episodes/ryan-flynn-of-harvard-on-non-coding-rna/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/mendelspod-podcast-742570/ryan-flynn-of-harvard-on-non-coding-rna.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]},{"title":"Gary Schroth on Connecting Cellular Behavior to the Transcriptome","slug":"gary-schroth-on-connecting-cellular-behavior-to-the-transcriptome","published_at":"2026-06-11T15:25:42+00:00","page_url":"https://stenobird.com/podcast/mendelspod-podcast-742570/gary-schroth-on-connecting-cellular-behavior-to-the-transcriptome","url":"https://www.mendelspod.com/p/gary-schroth-on-connecting-cellular","duration_seconds":1974,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/mendelspod-podcast-742570/episodes/gary-schroth-on-connecting-cellular-behavior-to-the-transcriptome/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/mendelspod-podcast-742570/gary-schroth-on-connecting-cellular-behavior-to-the-transcriptome.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]},{"title":"Two-Thirds of High-Risk Breast Cancer Patients May Avoid Chemotherapy According to Veracyte Data Presented at ASCO","slug":"two-thirds-of-high-risk-breast-cancer-patients-may-avoid-chemotherapy-according-to-veracyte-data-presented-at-asco","published_at":"2026-06-09T15:13:21+00:00","page_url":"https://stenobird.com/podcast/mendelspod-podcast-742570/two-thirds-of-high-risk-breast-cancer-patients-may-avoid-chemotherapy-according-to-veracyte-data-presented-at-asco","url":"https://www.mendelspod.com/p/two-thirds-of-high-risk-breast-cancer","duration_seconds":1626,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/mendelspod-podcast-742570/episodes/two-thirds-of-high-risk-breast-cancer-patients-may-avoid-chemotherapy-according-to-veracyte-data-presented-at-asco/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/mendelspod-podcast-742570/two-thirds-of-high-risk-breast-cancer-patients-may-avoid-chemotherapy-according-to-veracyte-data-presented-at-asco.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]},{"title":"Building the Diagnostic Layer of Modern Cancer Care with Rita Shaknovich and Karina Kulangara of Agilent","slug":"building-the-diagnostic-layer-of-modern-cancer-care-with-rita-shaknovich-and-karina-kulangara-of-agilent","published_at":"2026-05-29T16:01:06+00:00","page_url":"https://stenobird.com/podcast/mendelspod-podcast-742570/building-the-diagnostic-layer-of-modern-cancer-care-with-rita-shaknovich-and-karina-kulangara-of-agilent","url":"https://www.mendelspod.com/p/building-the-diagnostic-layer-of","duration_seconds":1891,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/mendelspod-podcast-742570/episodes/building-the-diagnostic-layer-of-modern-cancer-care-with-rita-shaknovich-and-karina-kulangara-of-agilent/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/mendelspod-podcast-742570/building-the-diagnostic-layer-of-modern-cancer-care-with-rita-shaknovich-and-karina-kulangara-of-agilent.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]},{"title":"Mapping the Multi-Omic Era with Eric Green of Illumina","slug":"mapping-the-multi-omic-era-with-eric-green-of-illumina","published_at":"2026-05-28T14:56:12+00:00","page_url":"https://stenobird.com/podcast/mendelspod-podcast-742570/mapping-the-multi-omic-era-with-eric-green-of-illumina","url":"https://www.mendelspod.com/p/mapping-the-multi-omic-era-with-eric","duration_seconds":2662,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/mendelspod-podcast-742570/episodes/mapping-the-multi-omic-era-with-eric-green-of-illumina/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/mendelspod-podcast-742570/mapping-the-multi-omic-era-with-eric-green-of-illumina.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]},{"title":"Inside Proteomics at Thermo Fisher with Yan Zhang","slug":"inside-proteomics-at-thermo-fisher-with-yan-zhang","published_at":"2026-05-21T15:45:57+00:00","page_url":"https://stenobird.com/podcast/mendelspod-podcast-742570/inside-proteomics-at-thermo-fisher-with-yan-zhang","url":"https://www.mendelspod.com/p/inside-proteomics-at-thermo-fisher","duration_seconds":274,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/mendelspod-podcast-742570/episodes/inside-proteomics-at-thermo-fisher-with-yan-zhang/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/mendelspod-podcast-742570/inside-proteomics-at-thermo-fisher-with-yan-zhang.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]},{"title":"Separating Epigenetic Signals Improves Early Cancer Detection with Rob Osborne, Biomodal","slug":"separating-epigenetic-signals-improves-early-cancer-detection-with-rob-osborne-biomodal","published_at":"2026-05-19T15:12:26+00:00","page_url":"https://stenobird.com/podcast/mendelspod-podcast-742570/separating-epigenetic-signals-improves-early-cancer-detection-with-rob-osborne-biomodal","url":"https://www.mendelspod.com/p/separating-epigenetic-signals-improves","duration_seconds":1399,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/mendelspod-podcast-742570/episodes/separating-epigenetic-signals-improves-early-cancer-detection-with-rob-osborne-biomodal/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/mendelspod-podcast-742570/separating-epigenetic-signals-improves-early-cancer-detection-with-rob-osborne-biomodal.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]},{"title":"Digital Controls for Cancer Drug Trials? Irina Babina, Concr","slug":"digital-controls-for-cancer-drug-trials-irina-babina-concr","published_at":"2026-05-15T14:55:30+00:00","page_url":"https://stenobird.com/podcast/mendelspod-podcast-742570/digital-controls-for-cancer-drug-trials-irina-babina-concr","url":"https://www.mendelspod.com/p/digital-controls-for-cancer-drug","duration_seconds":263,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/mendelspod-podcast-742570/episodes/digital-controls-for-cancer-drug-trials-irina-babina-concr/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/mendelspod-podcast-742570/digital-controls-for-cancer-drug-trials-irina-babina-concr.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]},{"title":"Solexa Co-Inventor Shankar Balasubramanian on Six-Base Sequencing and What's Next in Genomics","slug":"solexa-co-inventor-shankar-balasubramanian-on-six-base-sequencing-and-what-s-next-in-genomics","published_at":"2026-05-07T16:09:16+00:00","page_url":"https://stenobird.com/podcast/mendelspod-podcast-742570/solexa-co-inventor-shankar-balasubramanian-on-six-base-sequencing-and-what-s-next-in-genomics","url":"https://www.mendelspod.com/p/solexa-co-inventor-shankar-balasubramanian","duration_seconds":2279,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/mendelspod-podcast-742570/episodes/solexa-co-inventor-shankar-balasubramanian-on-six-base-sequencing-and-what-s-next-in-genomics/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/mendelspod-podcast-742570/solexa-co-inventor-shankar-balasubramanian-on-six-base-sequencing-and-what-s-next-in-genomics.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]},{"title":"The Next Frontier in Biology: Physics? Erdinc Sezgin of the Karolinska Institute","slug":"the-next-frontier-in-biology-physics-erdinc-sezgin-of-the-karolinska-institute","published_at":"2026-04-30T13:49:00+00:00","page_url":"https://stenobird.com/podcast/mendelspod-podcast-742570/the-next-frontier-in-biology-physics-erdinc-sezgin-of-the-karolinska-institute","url":"https://www.mendelspod.com/p/the-next-frontier-in-biology-physics","duration_seconds":1975,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/mendelspod-podcast-742570/episodes/the-next-frontier-in-biology-physics-erdinc-sezgin-of-the-karolinska-institute/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/mendelspod-podcast-742570/the-next-frontier-in-biology-physics-erdinc-sezgin-of-the-karolinska-institute.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]},{"title":"The Case for a 6-Base Genome with Peter Fromen, CEO of Biomodal","slug":"the-case-for-a-6-base-genome-with-peter-fromen-ceo-of-biomodal","published_at":"2026-04-28T14:52:57+00:00","page_url":"https://stenobird.com/podcast/mendelspod-podcast-742570/the-case-for-a-6-base-genome-with-peter-fromen-ceo-of-biomodal","url":"https://www.mendelspod.com/p/the-case-for-a-6-base-genome-with","duration_seconds":2129,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/mendelspod-podcast-742570/episodes/the-case-for-a-6-base-genome-with-peter-fromen-ceo-of-biomodal/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/mendelspod-podcast-742570/the-case-for-a-6-base-genome-with-peter-fromen-ceo-of-biomodal.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]},{"title":"The Eligible But Under-Tested:  Genomic Medicine in 2026 with Damon Hostin, Illumina","slug":"the-eligible-but-under-tested-genomic-medicine-in-2026-with-damon-hostin-illumina","published_at":"2026-04-14T14:08:46+00:00","page_url":"https://stenobird.com/podcast/mendelspod-podcast-742570/the-eligible-but-under-tested-genomic-medicine-in-2026-with-damon-hostin-illumina","url":"https://www.mendelspod.com/p/the-eligible-but-under-tested-genomic","duration_seconds":2376,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/mendelspod-podcast-742570/episodes/the-eligible-but-under-tested-genomic-medicine-in-2026-with-damon-hostin-illumina/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/mendelspod-podcast-742570/the-eligible-but-under-tested-genomic-medicine-in-2026-with-damon-hostin-illumina.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]},{"title":"Spatial Transcriptomics Is Changing How We Do Biology: Fei Chen, The Broad Institute","slug":"spatial-transcriptomics-is-changing-how-we-do-biology-fei-chen-the-broad-institute","published_at":"2026-04-09T20:27:52+00:00","page_url":"https://stenobird.com/podcast/mendelspod-podcast-742570/spatial-transcriptomics-is-changing-how-we-do-biology-fei-chen-the-broad-institute","url":"https://www.mendelspod.com/p/spatial-transcriptomics-is-changing","duration_seconds":1903,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/mendelspod-podcast-742570/episodes/spatial-transcriptomics-is-changing-how-we-do-biology-fei-chen-the-broad-institute/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/mendelspod-podcast-742570/spatial-transcriptomics-is-changing-how-we-do-biology-fei-chen-the-broad-institute.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]},{"title":"Beyond GLP-1: Why Peptides Are Back at the Center of Drug Discovery with Charlie Johannes and Tomi Sawyer","slug":"beyond-glp-1-why-peptides-are-back-at-the-center-of-drug-discovery-with-charlie-johannes-and-tomi-sawyer","published_at":"2026-04-07T15:46:31+00:00","page_url":"https://stenobird.com/podcast/mendelspod-podcast-742570/beyond-glp-1-why-peptides-are-back-at-the-center-of-drug-discovery-with-charlie-johannes-and-tomi-sawyer","url":"https://www.mendelspod.com/p/beyond-glp-1-why-peptides-are-back","duration_seconds":2646,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/mendelspod-podcast-742570/episodes/beyond-glp-1-why-peptides-are-back-at-the-center-of-drug-discovery-with-charlie-johannes-and-tomi-sawyer/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/mendelspod-podcast-742570/beyond-glp-1-why-peptides-are-back-at-the-center-of-drug-discovery-with-charlie-johannes-and-tomi-sawyer.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]},{"title":"From the Archives: Inventor Mark Kokoris Debuts Roche’s New SBX Sequencer","slug":"from-the-archives-inventor-mark-kokoris-debuts-roche-s-new-sbx-sequencer","published_at":"2026-04-02T16:37:20+00:00","page_url":"https://stenobird.com/podcast/mendelspod-podcast-742570/from-the-archives-inventor-mark-kokoris-debuts-roche-s-new-sbx-sequencer","url":"https://www.mendelspod.com/p/from-the-archives-inventor-mark-kokoris","duration_seconds":2151,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/mendelspod-podcast-742570/episodes/from-the-archives-inventor-mark-kokoris-debuts-roche-s-new-sbx-sequencer/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/mendelspod-podcast-742570/from-the-archives-inventor-mark-kokoris-debuts-roche-s-new-sbx-sequencer.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]},{"title":"Why Do Some Animals Live Ten Times Longer? Pursuing the Science of Aging with Steve Austad","slug":"why-do-some-animals-live-ten-times-longer-pursuing-the-science-of-aging-with-steve-austad","published_at":"2026-03-17T15:33:11+00:00","page_url":"https://stenobird.com/podcast/mendelspod-podcast-742570/why-do-some-animals-live-ten-times-longer-pursuing-the-science-of-aging-with-steve-austad","url":"https://www.mendelspod.com/p/why-do-some-animals-live-ten-times","duration_seconds":2302,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/mendelspod-podcast-742570/episodes/why-do-some-animals-live-ten-times-longer-pursuing-the-science-of-aging-with-steve-austad/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/mendelspod-podcast-742570/why-do-some-animals-live-ten-times-longer-pursuing-the-science-of-aging-with-steve-austad.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]},{"title":"MRD Testing: From Residual Disease to Real Decisions with Chris Hourigan and Gary Pestano","slug":"mrd-testing-from-residual-disease-to-real-decisions-with-chris-hourigan-and-gary-pestano","published_at":"2026-03-10T14:53:05+00:00","page_url":"https://stenobird.com/podcast/mendelspod-podcast-742570/mrd-testing-from-residual-disease-to-real-decisions-with-chris-hourigan-and-gary-pestano","url":"https://www.mendelspod.com/p/mrd-testing-from-residual-disease","duration_seconds":2013,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/mendelspod-podcast-742570/episodes/mrd-testing-from-residual-disease-to-real-decisions-with-chris-hourigan-and-gary-pestano/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/mendelspod-podcast-742570/mrd-testing-from-residual-disease-to-real-decisions-with-chris-hourigan-and-gary-pestano.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]},{"title":"Early vs Late Recurrence: How Multimodal AI Is Changing Breast Cancer Prognosis with George Sledge, Caris Life Sciences","slug":"early-vs-late-recurrence-how-multimodal-ai-is-changing-breast-cancer-prognosis-with-george-sledge-caris-life-sciences","published_at":"2026-03-05T16:02:18+00:00","page_url":"https://stenobird.com/podcast/mendelspod-podcast-742570/early-vs-late-recurrence-how-multimodal-ai-is-changing-breast-cancer-prognosis-with-george-sledge-caris-life-sciences","url":"https://www.mendelspod.com/p/early-vs-late-recurrence-how-multimodal","duration_seconds":246,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/mendelspod-podcast-742570/episodes/early-vs-late-recurrence-how-multimodal-ai-is-changing-breast-cancer-prognosis-with-george-sledge-caris-life-sciences/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/mendelspod-podcast-742570/early-vs-late-recurrence-how-multimodal-ai-is-changing-breast-cancer-prognosis-with-george-sledge-caris-life-sciences.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]},{"title":"The Dark Genome with Author Sudhakaran Prabakaran","slug":"the-dark-genome-with-author-sudhakaran-prabakaran","published_at":"2026-03-03T16:45:57+00:00","page_url":"https://stenobird.com/podcast/mendelspod-podcast-742570/the-dark-genome-with-author-sudhakaran-prabakaran","url":"https://www.mendelspod.com/p/the-dark-genome-with-author-sudhakaran","duration_seconds":2237,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/mendelspod-podcast-742570/episodes/the-dark-genome-with-author-sudhakaran-prabakaran/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/mendelspod-podcast-742570/the-dark-genome-with-author-sudhakaran-prabakaran.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]},{"title":"Illumina's New Mapped Read Technology Provides Insights into Rare Disease: Stephen Kingsmore, Olivia Kim-McManus and Ali Crawford","slug":"illumina-s-new-mapped-read-technology-provides-insights-into-rare-disease-stephen-kingsmore-olivia-kim-mcmanus-and-ali-crawford","published_at":"2026-02-26T16:20:45+00:00","page_url":"https://stenobird.com/podcast/mendelspod-podcast-742570/illumina-s-new-mapped-read-technology-provides-insights-into-rare-disease-stephen-kingsmore-olivia-kim-mcmanus-and-ali-crawford","url":"https://www.mendelspod.com/p/illuminas-new-mapped-read-technology","duration_seconds":1635,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/mendelspod-podcast-742570/episodes/illumina-s-new-mapped-read-technology-provides-insights-into-rare-disease-stephen-kingsmore-olivia-kim-mcmanus-and-ali-crawford/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/mendelspod-podcast-742570/illumina-s-new-mapped-read-technology-provides-insights-into-rare-disease-stephen-kingsmore-olivia-kim-mcmanus-and-ali-crawford.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]},{"title":"CareDx’s Second Act with CEO John Hanna","slug":"caredx-s-second-act-with-ceo-john-hanna","published_at":"2026-02-17T16:40:45+00:00","page_url":"https://stenobird.com/podcast/mendelspod-podcast-742570/caredx-s-second-act-with-ceo-john-hanna","url":"https://www.mendelspod.com/p/caredxs-second-act-with-ceo-john","duration_seconds":328,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/mendelspod-podcast-742570/episodes/caredx-s-second-act-with-ceo-john-hanna/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/mendelspod-podcast-742570/caredx-s-second-act-with-ceo-john-hanna.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]},{"title":"Inside GP2: Building a Global Genetic Map of Parkinson’s with Andrew Singleton and Ignacio Mata","slug":"inside-gp2-building-a-global-genetic-map-of-parkinson-s-with-andrew-singleton-and-ignacio-mata","published_at":"2026-02-10T16:23:04+00:00","page_url":"https://stenobird.com/podcast/mendelspod-podcast-742570/inside-gp2-building-a-global-genetic-map-of-parkinson-s-with-andrew-singleton-and-ignacio-mata","url":"https://www.mendelspod.com/p/inside-gp2-building-a-global-genetic","duration_seconds":2444,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/mendelspod-podcast-742570/episodes/inside-gp2-building-a-global-genetic-map-of-parkinson-s-with-andrew-singleton-and-ignacio-mata/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/mendelspod-podcast-742570/inside-gp2-building-a-global-genetic-map-of-parkinson-s-with-andrew-singleton-and-ignacio-mata.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]},{"title":"A Simple Sponge, a Big Shift in Cell Therapy with Yev Brudno, UNC","slug":"a-simple-sponge-a-big-shift-in-cell-therapy-with-yev-brudno-unc","published_at":"2026-02-03T16:28:28+00:00","page_url":"https://stenobird.com/podcast/mendelspod-podcast-742570/a-simple-sponge-a-big-shift-in-cell-therapy-with-yev-brudno-unc","url":"https://www.mendelspod.com/p/a-simple-sponge-a-big-shift-in-cell","duration_seconds":1840,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/mendelspod-podcast-742570/episodes/a-simple-sponge-a-big-shift-in-cell-therapy-with-yev-brudno-unc/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/mendelspod-podcast-742570/a-simple-sponge-a-big-shift-in-cell-therapy-with-yev-brudno-unc.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]},{"title":"How Cellanome Is Changing the Way We Study Cell Function with Matthew Spitzer and Pier Federico Gherardini","slug":"how-cellanome-is-changing-the-way-we-study-cell-function-with-matthew-spitzer-and-pier-federico-gherardini","published_at":"2026-01-29T16:19:51+00:00","page_url":"https://stenobird.com/podcast/mendelspod-podcast-742570/how-cellanome-is-changing-the-way-we-study-cell-function-with-matthew-spitzer-and-pier-federico-gherardini","url":"https://www.mendelspod.com/p/how-cellanome-is-changing-the-way","duration_seconds":1437,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/mendelspod-podcast-742570/episodes/how-cellanome-is-changing-the-way-we-study-cell-function-with-matthew-spitzer-and-pier-federico-gherardini/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/mendelspod-podcast-742570/how-cellanome-is-changing-the-way-we-study-cell-function-with-matthew-spitzer-and-pier-federico-gherardini.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]},{"title":"From Hereditary Risk to Residual Disease: Natera’s Integrated Vision for Precision Oncology with Adam ElNaggar, MD","slug":"from-hereditary-risk-to-residual-disease-natera-s-integrated-vision-for-precision-oncology-with-adam-elnaggar-md","published_at":"2026-01-28T16:30:41+00:00","page_url":"https://stenobird.com/podcast/mendelspod-podcast-742570/from-hereditary-risk-to-residual-disease-natera-s-integrated-vision-for-precision-oncology-with-adam-elnaggar-md","url":"https://www.mendelspod.com/p/from-hereditary-risk-to-residual","duration_seconds":2519,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/mendelspod-podcast-742570/episodes/from-hereditary-risk-to-residual-disease-natera-s-integrated-vision-for-precision-oncology-with-adam-elnaggar-md/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/mendelspod-podcast-742570/from-hereditary-risk-to-residual-disease-natera-s-integrated-vision-for-precision-oncology-with-adam-elnaggar-md.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]}]}